Viewing Study NCT01419704

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 9:07 PM
Ignite Modification Date: 2026-03-28 @ 8:33 AM
Study NCT ID: NCT01419704
Status: WITHDRAWN
Last Update Posted: 2023-03-03
First Post: 2011-08-16
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Phase I/II Pilot Study of Mixed Chimerism to Treat Hemoglobinopathies
Sponsor: Talaris Therapeutics Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Anemia, Sickle Cell View
None Complex and Transfusion-dependent Hemoglobinopathies View
None Thalassemia View
None Diamond-Blackfan Anemia View
None Bone Marrow Failure Syndromes View
None Alpha-Thalassemia View
None Beta-Thalassemia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None other hemoglobinopathies View
None chimerism View
None sickle cell View
None thalassemia View
None Marrow/Enriched Hematopoetic Stem Cell Transplant View